Newbridge Financial Services Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.23K | Hold |
14
| – | – | ﹤0.01% | 988 |
|
|
2025
Q1 | $6.79K | Buy |
+14
| New | +$6.79K | ﹤0.01% | 749 |
|
|
2024
Q4 | – | Sell |
-14
| Closed | -$6.51K | – | 1185 |
|
|
2024
Q3 | $6.51K | Buy |
+14
| New | +$6.51K | ﹤0.01% | 478 |
|
|
2024
Q1 | – | Sell |
-24
| Closed | -$9.77K | – | 1313 |
|
|
2023
Q4 | $9.77K | Sell |
24
-59
| -71% | -$24K | ﹤0.01% | 740 |
|
|
2023
Q3 | $28.9K | Buy |
83
+18
| +28% | +$6.26K | 0.01% | 558 |
|
|
2023
Q2 | $22.9K | Hold |
65
| – | – | 0.01% | 658 |
|
|
2023
Q1 | $20.5K | Sell |
65
-4
| -6% | -$1.26K | 0.01% | 713 |
|
|
2022
Q4 | $19.9K | Hold |
69
| – | – | 0.01% | 719 |
|
|
2022
Q3 | $20K | Sell |
69
-9
| -12% | -$2.61K | 0.01% | 700 |
|
|
2022
Q2 | $22K | Sell |
78
-70
| -47% | -$19.7K | 0.01% | 638 |
|
|
2022
Q1 | $39K | Hold |
148
| – | – | 0.02% | 543 |
|
|
2021
Q4 | $33K | Hold |
148
| – | – | 0.02% | 590 |
|
|
2021
Q3 | $27K | Hold |
148
| – | – | 0.02% | 585 |
|
|
2021
Q2 | $30K | Sell |
148
-36
| -20% | -$7.3K | 0.02% | 646 |
|
|
2021
Q1 | $40K | Buy |
184
+29
| +19% | +$6.3K | 0.03% | 452 |
|
|
2020
Q4 | $37K | Sell |
155
-288
| -65% | -$68.7K | 0.03% | 401 |
|
|
2020
Q3 | $121K | Buy |
+443
| New | +$121K | 0.12% | 177 |
|